Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from XRAY

Dentsply Sirona Maintains Outlook Despite Sales Decline

Dentsply Sirona Inc. (NASDAQ:XRAY) shares are trading lower on Thursday.

Benzinga · Aug 7, 2025

3 Dental Stocks That Will Keep You Smiling in 2022

The rebound in demand for dental care services and products with the easing of COVID-19 fears and adoption of advanced technologies in dental care bode well for the dental industry. Therefore, we think the stocks of quality dental companies Dentsply Sirona (XRAY), Patterson Companies (PDCO), and Henry Schein (HSIC) could…

StockNews.com · Jun 3, 2022

Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance

Dentsply Sirona Inc's (NASDAQ:XRAY) Q1 FY22 sales decreased 6.1% Y/Y to $965 million, missing the consensus of $988.43 billion. Adjusted EPS decreased to $0.52 from $0.72 a year ago and missed the consensus of $0.56. "The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact…

Benzinga · May 10, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Read Why HC Wainwright Cut Price Target For Dentsply Sirona

HC Wainwright has cut the price target for Dentsply Sirona Inc (NASDAQ:XRAY) from $58 to $48 (17% upside), reiterating the Neutral rating. The analysts have adjusted 2022 projections to reflect lower than expected Q1 FY22 earnings. Management noted that the results reflect weaker sales performance in the U.S., global supply chain challenges, and foreign exchange headwinds.…

Benzinga · Apr 22, 2022

Expert Ratings for Dentsply Sirona

Over the past 3 months, 7 analysts have published their opinion on Dentsply Sirona (NASDAQ:XRAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Apr 20, 2022

Why Are Dentsply Sirona Shares Plummeting Today?

Dentsply Sirona Inc (NASDAQ:XRAY) appointed John Groetelaars, who serves on Dentsply Sirona's Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO, and will cease to serve as a member of the Company's Board, effective immediately. The Board has initiated a search to identify…

Benzinga · Apr 19, 2022

What 4 Analyst Ratings Have To Say About Dentsply Sirona

Within the last quarter, Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings:

Benzinga · Mar 1, 2022

Read news from The Economist, FT, and more,
with one subscription

Dentsply Sirona's Return On Capital Employed Overview

According to Benzinga Pro data Dentsply Sirona (NASDAQ:XRAY) posted a 0.97% decrease in earnings from Q3. Sales, however, increased by 1.78% over the previous quarter to $1.09 billion.

Benzinga · Mar 1, 2022

Dentsply Sirona's Q4 Falls Short Of Expectations, FY22 Sales Outlook Lags Street View

Dentsply Sirona Inc's (NASDAQ: XRAY)

Benzinga · Feb 28, 2022

Coverage From

Organisations

Medical – Devices & Equipment

14 stories

PDCO

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

430,401 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.